Sanofi Consumer

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0UOS01011
  • NSEID: SANOFICONR
  • BSEID: 544250
INR
3,449.50
-39.7 (-1.14%)
BSENSE

Nov 20

BSE+NSE Vol: 5.21 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 11.62% vs 2.84% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is 11.34% vs 1.47% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 13.89% vs 0.56% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -25.00% vs -20.00% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Sanofi Consumer With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
263.10
659.91
-396.81
-60.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
263.10
659.91
-396.81
-60.13%
Raw Material Cost
40.70
303.21
-262.51
-86.58%
Purchase of Finished goods
11.60
44.54
-32.94
-73.96%
(Increase) / Decrease In Stocks
12.10
17.02
-4.92
-28.91%
Employee Cost
30.70
107.92
-77.22
-71.55%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
66.30
115.80
-49.50
-42.75%
Total Expenditure (Excl Depreciation)
161.40
588.49
-427.09
-72.57%
Operating Profit (PBDIT) excl Other Income
101.70
71.42
30.28
42.40%
Other Income
4.40
1.38
3.02
218.84%
Operating Profit (PBDIT)
106.10
72.80
33.30
45.74%
Interest
0.30
27.76
-27.46
-98.92%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
105.80
45.04
60.76
134.90%
Depreciation
3.10
27.81
-24.71
-88.85%
Profit Before Tax
102.70
17.23
85.47
496.05%
Tax
26.10
7.97
18.13
227.48%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
76.60
9.26
67.34
727.21%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
76.60
9.26
67.34
727.21%
Equity Capital
23.00
92.17
-69.17
-75.05%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
33.30
1.00
32.30
3,230.00%
Diluted Earnings per share
33.26
1.00
32.26
3,226.00%
Operating Profit Margin (Excl OI)
38.65%
10.82%
0.00
27.83%
Gross Profit Margin
40.21%
6.83%
0.00
33.38%
PAT Margin
29.11%
1.40%
0.00
27.71%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 263.10 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 11.62% vs 2.84% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 12.48% vs 46.28% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 76.60 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 11.34% vs 1.47% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 21.78% vs 39.78% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 101.70 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 13.89% vs 0.56% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 19.65% vs 34.71% in Sep 2025

Quarterly - Interest
Interest 0.30 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -25.00% vs -20.00% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -50.00% vs -82.35% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.65%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025